Adverse events ‐ serious · paediatric patients with diarrhoea due to Shiga toxin‐producing E. coli
Urtoxazumab (3.0 mg/kg) may leads to lower adverse events ‐ serious compared with placebo (low certainty).
1 finding from 1 review
Adverse events ‐ serious · paediatric patients with diarrhoea due to Shiga toxin‐producing E. coli
1 finding from 1 review
Alopecia · healthy men
Selenium leads to higher adverse events: alopecia compared with placebo (high certainty).
1 finding from 1 review
Intervention not reported
Adverse events Length of · and
It is very uncertain whether the intervention changes adverse events Length of (very low certainty).
1 finding from 1 review
Adverse events Length of · and
2 findings from 1 review
Adverse events Length of · and
1 finding from 1 review
Adverse events Length of · and
1 finding from 1 review
Adverse events Length of · and
1 finding from 1 review
Adverse events Length of · and
It is very uncertain whether summary of findings: General medication review changes adverse events Length of compared with usual care (very low certainty).
1 finding from 1 review
Adverse events: backache · patients undergoing lumbar punctures with atraumatic needles (Whitacre, Atraucan, Sprotte, Cappe‐Deutsh, Pajunk, Gertie Marx, Durasafe,…
Larger atraumatic needles probably leads to lower adverse events: backache compared with smaller atraumatic needles (moderate certainty).
1 finding from 1 review
Adverse events: backache · participants undergoing lumbar puncture
Traumatic needles showed no clear difference in adverse events: backache compared with atraumatic needles (moderate certainty).
1 finding from 1 review
Proportion of children with adverse events · children with nocturnal enuresis
Alarm probably leads to lower proportion of children with adverse events compared with desmopressin (moderate certainty).
1 finding from 1 review
Adverse events: hypertension with seizures · idiopathic steroid‐resistant nephrotic syndrome in children
It is very uncertain whether oral cyclophosphamide changes adverse events: hypertension with seizures compared with prednisone or placebo (very low certainty).
1 finding from 1 review
Withdrawals due to adverse events · active EoE pediatric patients
It is very uncertain whether swallowed fluticasone changes withdrawals due to adverse events at 4 weeks compared with oral prednisone (very low certainty).
1 finding from 1 review
Adverse events: hair loss · SSNS in children
Intravenous showed no clear difference in adverse events: hair loss compared with oral cyclophosphamide (low certainty).
1 finding from 1 review
Intervention not reported
Adverse events ‐ myopathy · people with cardiovascular disease or at high risk of cardiovascular disease
It is very uncertain whether the intervention changes adverse events ‐ myopathy (very low certainty).
1 finding from 1 review
Adverse events: severe complications at day 21 · bullous pemphigoid
Clobetasol propionate cream may leads to lower adverse events: severe complications at day 21 compared with oral prednisone (low certainty).
1 finding from 1 review
Discontinuation of medication due to adverse events · Women of reproductive age seeking to avoid pregnancy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events (treatment related) To discharge · newborn infants with opioid withdrawal
It is very uncertain whether morphine changes adverse events (treatment‐related) To discharge compared with buprenorphine (very low certainty).
1 finding from 1 review
Withdrawals due to adverse events · adults with primary (essential) hypertension whose systolic or diastolic (or both) blood pressure levels were 130/80 mmHg or greater
It is very uncertain whether evening changes withdrawals from treatment due to adverse events compared with morning dosing regimen (very low certainty).
1 finding from 1 review